Affordable Care Act (ACA) marketplace enrollment

Open enrollment for Affordable Care Act plans available through HealthCare.gov is from November 1 to January 15. Keep your ARC care team by choosing from insurance plans we accept: Aetna, Ambetter, Blue Cross, Blue Advantage, MyBlue, Moda, Sendero, and UnitedHealthcare Exchange Plan.

All insurance plans accepted by ARC, including government plans, are listed online at ARCInsuranceInfo.com.

Medicare annual enrollment

Eligible U.S. residents can apply for and make changes to their Medicare plans from October 15 – December 7. Medicare is a health insurance plan for people ages 65 and up, or those with certain conditions or disabilities. It is important to know your options and pick a plan that lets you keep your ARC care team.

Medicare patients at ARC are 7.5% less likely to use the ER than other patients across the nation.

Tips for patients

ARC in-network with UHC

If you have received a letter from UnitedHealthcare (UHC) stating that any of the providers listed below are out-of-network, please be informed that refers to their former practice. The following physicians and APC remain in-network at ARC, and you may continue seeing them without any changes to your coverage:

MyChart Login Help Me Book

Enrolling Studies

The research team at ARC is currently managing several different clinical studies. Are you interested in a particular study opportunity? Information about current study opportunities currently enrolling patients can be found below. Both ARC patients and non-ARC patients who fit the trial eligibility requirements are welcome.

  • BaxDuo Arctic Chronic Kidney Disease (CKD) Clinical Study

    A phase III, randomized, double-blind, active-controlled study intended to assess the efficacy, safety, and tolerability of baxdrostat in combination with dapagliflozin compared with dapagliflozin alone on chronic kidney disease (CKD) progression in participants with CKD and high blood pressure.

    About the Study
  • Clinical Biospecimen Collection for Alzheimer's and Parkinson's Disease Biomarker Research

    Biospecimen collection for subjects with clinically established Alzheimer's or Parkinson's Disease to support biomarker research. Must be willing to undergo a 1-time blood draw and urine collection.

    About the Study
  • Credo SARS-CoV-2, Flu, and RSV Clinical Study

    Clinical performance evaluation of the VitaSIRO solo™ SARSCoV-2/Flu/RSV Assay.

    About the Study
  • ENABLE Multiple Sclerosis (MS) Clinical Study

    A long-term observational registry study for patients with multiple sclerosis (MS) to collect real-world data on BRIUMVI (infusion medication) and assess efficacy, safety, and tolerability of medication.

    About the Study
  • SQNM COVID-19, Flu, and RSV Swab Sample Study

    The SQNM swab study is collecting swab samples from patients experiencing symptoms of flu A, flu B, RSV, and/or COVID-19, which will support the development of a test to detect these viruses.

    About the Study
  • Trailblazer Alzheimer’s Disease Study

    A long-term, real-world study comparing the effectiveness of Donanemab along with usual care to usual care alone in U.S. patients with early symptomatic Alzheimer’s Disease.

    About the Study
  • Zenith Chronic Kidney Disease (CKD) and High Proteinuria Study

    A phase III trial to assess the efficacy, safety, and tolerability of zibotentan combined with dapagliflozin, compared to dapagliflozin alone, in participants with chronic kidney disease and high proteinuria.

    About the Study